Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...
Early results of Eli Lilly’s next generation of weight loss drugs appear to show promise, possibly leading to even faster ...
For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.
Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...